Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Nov 15;360(Pt 1):189–198. doi: 10.1042/0264-6021:3600189

Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors.

R R Flörke 1, K Schnaith 1, W Passlack 1, M Wichert 1, L Kuehn 1, M Fabry 1, M Federwisch 1, H Reinauer 1
PMCID: PMC1222217  PMID: 11696007

Abstract

Interaction between two alphabeta half-receptors within the (alphabeta)(2) holoreceptor complex is required for insulin binding with high affinity and for insulin-triggered changes of size and shape. To understand the underlying structure-function relationship, two truncated receptor constructs have been characterized. Reduction in the Stokes radius and increase in the sedimentation coefficient, which are characteristic for wild-type receptors, were entirely lacking for the recombinant human insulin receptor (HIR) ectodomain (HIR-ED). Stokes radii of about 5.8 nm and sedimentation coefficients of 10.2 S were found for both insulin-bound and free HIR-EDs. However, attaching the membrane anchors to the ectodomain, as with the recombinant membrane-anchored ectodomain (HIR-MAED) construct, was sufficient to restore not only high-affinity hormone binding but also the marked insulin-inducible alterations in hydrodynamic properties. The Stokes radii of HIR-MAED complexes, as assessed by non-denaturing PAGE, decreased upon insulin binding from 9.5 nm to 7.9 nm. In parallel, the sedimentation coefficient was increased from 9.0 S to 9.8 S. CD and fluorescence spectroscopy of HIR-MAED revealed only minor insulin-induced changes in the secondary structure. Similarity with wild-type receptors has also been demonstrated by the differential insertion of insulin-bound and free HIR-MAED complexes into artificial bilayer membranes of Triton X-114. The results are consistent with a model of receptor function that ensures a global insulin-triggered reorientation of subdomains within the ectodomain moieties while the secondary structure is essentially retained. For the rearrangement of such subdomains, the transmembrane anchors confer essential structural constraints on the receptor ectodomain.

Full Text

The Full Text of this article is available as a PDF (322.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams T. E., Epa V. C., Garrett T. P., Ward C. W. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci. 2000 Jul;57(7):1050–1093. doi: 10.1007/PL00000744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersen A. S., Kjeldsen T., Wiberg F. C., Vissing H., Schäffer L., Rasmussen J. S., De Meyts P., Møller N. P. Identification of determinants that confer ligand specificity on the insulin receptor. J Biol Chem. 1992 Jul 5;267(19):13681–13686. [PubMed] [Google Scholar]
  3. Bajaj M., Waterfield M. D., Schlessinger J., Taylor W. R., Blundell T. On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. Biochim Biophys Acta. 1987 Nov 26;916(2):220–226. doi: 10.1016/0167-4838(87)90112-9. [DOI] [PubMed] [Google Scholar]
  4. Bass J., Kurose T., Pashmforoush M., Steiner D. F. Fusion of insulin receptor ectodomains to immunoglobulin constant domains reproduces high-affinity insulin binding in vitro. J Biol Chem. 1996 Aug 9;271(32):19367–19375. doi: 10.1074/jbc.271.32.19367. [DOI] [PubMed] [Google Scholar]
  5. Bucci E., Steiner R. F. Anisotropy decay of fluorescence as an experimental approach to protein dynamics. Biophys Chem. 1988 Jul 15;30(3):199–224. doi: 10.1016/0301-4622(88)85017-8. [DOI] [PubMed] [Google Scholar]
  6. Böni-Schnetzler M., Scott W., Waugh S. M., DiBella E., Pilch P. F. The insulin receptor. Structural basis for high affinity ligand binding. J Biol Chem. 1987 Jun 15;262(17):8395–8401. [PubMed] [Google Scholar]
  7. Christiansen K., Tranum-Jensen J., Carlsen J., Vinten J. A model for the quaternary structure of human placental insulin receptor deduced from electron microscopy. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):249–252. doi: 10.1073/pnas.88.1.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De Meyts P. The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia. 1994 Sep;37 (Suppl 2):S135–S148. doi: 10.1007/BF00400837. [DOI] [PubMed] [Google Scholar]
  9. Ellis L., Sissom J., Levitan A. Truncation of the ectodomain of the human insulin receptor results in secretion of a soluble insulin binding protein from transfected CHO cells. J Mol Recognit. 1988 Feb;1(1):25–31. doi: 10.1002/jmr.300010106. [DOI] [PubMed] [Google Scholar]
  10. Ellis L., Tavaré J. M., Levine B. A. Insulin receptor tyrosine kinase structure and function. Biochem Soc Trans. 1991 Apr;19(2):426–432. doi: 10.1042/bst0190426. [DOI] [PubMed] [Google Scholar]
  11. Fabry M., Schaefer E., Ellis L., Kojro E., Fahrenholz F., Brandenburg D. Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J Biol Chem. 1992 May 5;267(13):8950–8956. [PubMed] [Google Scholar]
  12. Flörke R. R., Klein H. W., Reinauer H. Differential insertion of insulin receptor complexes into Triton X-114 bilayer membranes. Evidence for a differential accessibility of the membrane-exposed receptor domain. Eur J Biochem. 1993 Jan 15;211(1-2):241–247. doi: 10.1111/j.1432-1033.1993.tb19892.x. [DOI] [PubMed] [Google Scholar]
  13. Flörke R. R., Klein H. W., Reinauer H. Structural requirements for signal transduction of the insulin receptor. Eur J Biochem. 1990 Jul 31;191(2):473–482. doi: 10.1111/j.1432-1033.1990.tb19146.x. [DOI] [PubMed] [Google Scholar]
  14. Gardin A., Auzan C., Clauser E., Malherbe T., Aunis D., Crémel G., Hubert P. Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action. FASEB J. 1999 Aug;13(11):1347–1357. doi: 10.1096/fasebj.13.11.1347. [DOI] [PubMed] [Google Scholar]
  15. Garrett T. P., McKern N. M., Lou M., Frenkel M. J., Bentley J. D., Lovrecz G. O., Elleman T. C., Cosgrove L. J., Ward C. W. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature. 1998 Jul 23;394(6691):395–399. doi: 10.1038/28668. [DOI] [PubMed] [Google Scholar]
  16. Goncalves E., Yamada K., Thatte H. S., Backer J. M., Golan D. E., Kahn C. R., Shoelson S. E. Optimizing transmembrane domain helicity accelerates insulin receptor internalization and lateral mobility. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5762–5766. doi: 10.1073/pnas.90.12.5762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haft C. R., Taylor S. I. Deletion of 343 amino acids from the carboxyl terminus of the beta-subunit of the insulin receptor inhibits insulin signaling. Biochemistry. 1994 Aug 9;33(31):9143–9151. doi: 10.1021/bi00197a017. [DOI] [PubMed] [Google Scholar]
  18. Hoyne P. A., Cosgrove L. J., McKern N. M., Bentley J. D., Ivancic N., Elleman T. C., Ward C. W. High affinity insulin binding by soluble insulin receptor extracellular domain fused to a leucine zipper. FEBS Lett. 2000 Aug 11;479(1-2):15–18. doi: 10.1016/s0014-5793(00)01872-x. [DOI] [PubMed] [Google Scholar]
  19. Hubbard S. R. Structural analysis of receptor tyrosine kinases. Prog Biophys Mol Biol. 1999;71(3-4):343–358. doi: 10.1016/s0079-6107(98)00047-9. [DOI] [PubMed] [Google Scholar]
  20. Johnson J. D., Wong M. L., Rutter W. J. Properties of the insulin receptor ectodomain. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7516–7520. doi: 10.1073/pnas.85.20.7516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kadowaki T., Tobe K., Honda-Yamamoto R., Tamemoto H., Kaburagi Y., Momomura K., Ueki K., Takahashi Y., Yamauchi T., Akanuma Y. Signal transduction mechanism of insulin and insulin-like growth factor-1. Endocr J. 1996 Oct;43 (Suppl):S33–S41. doi: 10.1507/endocrj.43.suppl_s33. [DOI] [PubMed] [Google Scholar]
  22. Kristensen C., Wiberg F. C., Andersen A. S. Specificity of insulin and insulin-like growth factor I receptors investigated using chimeric mini-receptors. Role of C-terminal of receptor alpha subunit. J Biol Chem. 1999 Dec 24;274(52):37351–37356. doi: 10.1074/jbc.274.52.37351. [DOI] [PubMed] [Google Scholar]
  23. Lee J., Pilch P. F., Shoelson S. E., Scarlata S. F. Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy. Biochemistry. 1997 Mar 4;36(9):2701–2708. doi: 10.1021/bi961815g. [DOI] [PubMed] [Google Scholar]
  24. Lee J., Pilch P. F. The insulin receptor: structure, function, and signaling. Am J Physiol. 1994 Feb;266(2 Pt 1):C319–C334. doi: 10.1152/ajpcell.1994.266.2.C319. [DOI] [PubMed] [Google Scholar]
  25. Li S. C., Deber C. M., Shoelson S. E. An irregularity in the transmembrane domain helix correlates with the rate of insulin receptor internalization. Biochemistry. 1994 Nov 29;33(47):14333–14338. doi: 10.1021/bi00251a047. [DOI] [PubMed] [Google Scholar]
  26. Luo R. Z., Beniac D. R., Fernandes A., Yip C. C., Ottensmeyer F. P. Quaternary structure of the insulin-insulin receptor complex. Science. 1999 Aug 13;285(5430):1077–1080. doi: 10.1126/science.285.5430.1077. [DOI] [PubMed] [Google Scholar]
  27. Marino-Buslje C., Martin-Martinez M., Mizuguchi K., Siddle K., Blundell T. L. The insulin receptor: from protein sequence to structure. Biochem Soc Trans. 1999 Aug;27(4):715–726. doi: 10.1042/bst0270715. [DOI] [PubMed] [Google Scholar]
  28. McClain D. A., Maegawa H., Levy J., Huecksteadt T., Dull T. J., Lee J., Ullrich A., Olefsky J. M. Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation, and endocytosis. J Biol Chem. 1988 Jun 25;263(18):8904–8911. [PubMed] [Google Scholar]
  29. Munro I., Pecht I., Stryer L. Subnanosecond motions of tryptophan residues in proteins. Proc Natl Acad Sci U S A. 1979 Jan;76(1):56–60. doi: 10.1073/pnas.76.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mynarcik D. C., Williams P. F., Schaffer L., Yu G. Q., Whittaker J. Analog binding properties of insulin receptor mutants. Identification of amino acids interacting with the COOH terminus of the B-chain of the insulin molecule. J Biol Chem. 1997 Jan 24;272(4):2077–2081. doi: 10.1074/jbc.272.4.2077. [DOI] [PubMed] [Google Scholar]
  31. Pilch P. F., Czech M. P. The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes. J Biol Chem. 1980 Feb 25;255(4):1722–1731. [PubMed] [Google Scholar]
  32. Sasaoka T., Takata Y., Kusari J., Anderson C. M., Langlois W. J., Olefsky J. M. Transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4379–4383. doi: 10.1073/pnas.90.10.4379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schaefer E. M., Erickson H. P., Federwisch M., Wollmer A., Ellis L. Structural organization of the human insulin receptor ectodomain. J Biol Chem. 1992 Nov 15;267(32):23393–23402. [PubMed] [Google Scholar]
  34. Schlein M., Havelund S., Kristensen C., Dunn M. F., Kaarsholm N. C. Ligand-induced conformational change in the minimized insulin receptor. J Mol Biol. 2000 Oct 20;303(2):161–169. doi: 10.1006/jmbi.2000.4134. [DOI] [PubMed] [Google Scholar]
  35. Schumacher R., Soos M. A., Schlessinger J., Brandenburg D., Siddle K., Ullrich A. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J Biol Chem. 1993 Jan 15;268(2):1087–1094. [PubMed] [Google Scholar]
  36. Schäffer L. A model for insulin binding to the insulin receptor. Eur J Biochem. 1994 May 1;221(3):1127–1132. doi: 10.1111/j.1432-1033.1994.tb18833.x. [DOI] [PubMed] [Google Scholar]
  37. Sweet L. J., Morrison B. D., Pessin J. E. Isolation of functional alpha beta heterodimers from the purified human placental alpha 2 beta 2 heterotetrameric insulin receptor complex. A structural basis for insulin binding heterogeneity. J Biol Chem. 1987 May 25;262(15):6939–6942. [PubMed] [Google Scholar]
  38. Taylor S. S., Radzio-Andzelm E., Hunter T. How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J. 1995 Oct;9(13):1255–1266. doi: 10.1096/fasebj.9.13.7557015. [DOI] [PubMed] [Google Scholar]
  39. Tranum-Jensen J., Christiansen K., Carlsen J., Brenzel G., Vinten J. Membrane topology of insulin receptors reconstituted into lipid vesicles. J Membr Biol. 1994 Jun;140(3):215–223. doi: 10.1007/BF00233710. [DOI] [PubMed] [Google Scholar]
  40. Tulloch P. A., Lawrence L. J., McKern N. M., Robinson C. P., Bentley J. D., Cosgrove L., Ivancic N., Lovrecz G. O., Siddle K., Ward C. W. Single-molecule imaging of human insulin receptor ectodomain and its Fab complexes. J Struct Biol. 1999 Mar;125(1):11–18. doi: 10.1006/jsbi.1998.4066. [DOI] [PubMed] [Google Scholar]
  41. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  42. Van Obberghen E. Signalling through the insulin receptor and the insulin-like growth factor-I receptor. Diabetologia. 1994 Sep;37 (Suppl 2):S125–S134. doi: 10.1007/BF00400836. [DOI] [PubMed] [Google Scholar]
  43. Waugh S. M., DiBella E. E., Pilch P. F. Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding. Biochemistry. 1989 Apr 18;28(8):3448–3455. doi: 10.1021/bi00434a045. [DOI] [PubMed] [Google Scholar]
  44. White M. F. The IRS-signalling system in insulin and cytokine action. Philos Trans R Soc Lond B Biol Sci. 1996 Feb 29;351(1336):181–189. doi: 10.1098/rstb.1996.0015. [DOI] [PubMed] [Google Scholar]
  45. Whittaker J., Garcia P., Yu G. Q., Mynarcik D. C. Transmembrane domain interactions are necessary for negative cooperativity of the insulin receptor. Mol Endocrinol. 1994 Nov;8(11):1521–1527. doi: 10.1210/mend.8.11.7877620. [DOI] [PubMed] [Google Scholar]
  46. Whittaker J., Okamoto A. Secretion of soluble functional insulin receptors by transfected NIH3T3 cells. J Biol Chem. 1988 Mar 5;263(7):3063–3066. [PubMed] [Google Scholar]
  47. Williams P. F., Mynarcik D. C., Yu G. Q., Whittaker J. Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis. J Biol Chem. 1995 Feb 17;270(7):3012–3016. doi: 10.1074/jbc.270.7.3012. [DOI] [PubMed] [Google Scholar]
  48. Woldin C. N., Hing F. S., Lee J., Pilch P. F., Shipley G. G. Structural studies of the detergent-solubilized and vesicle-reconstituted insulin receptor. J Biol Chem. 1999 Dec 3;274(49):34981–34992. doi: 10.1074/jbc.274.49.34981. [DOI] [PubMed] [Google Scholar]
  49. Yamada K., Carpentier J. L., Cheatham B., Goncalves E., Shoelson S. E., Kahn C. R. Role of the transmembrane domain and flanking amino acids in internalization and down-regulation of the insulin receptor. J Biol Chem. 1995 Feb 17;270(7):3115–3122. doi: 10.1074/jbc.270.7.3115. [DOI] [PubMed] [Google Scholar]
  50. Yamada K., Goncalves E., Carpentier J. L., Kahn C. R., Shoelson S. E. Transmembrane domain inversion blocks ER release and insulin receptor signaling. Biochemistry. 1995 Jan 24;34(3):946–954. doi: 10.1021/bi00003a029. [DOI] [PubMed] [Google Scholar]
  51. Yamada K., Goncalves E., Kahn C. R., Shoelson S. E. Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro. J Biol Chem. 1992 Jun 25;267(18):12452–12461. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES